اوجاقی, حبیب ، معصومی, رحیم ، اسکندری ثانی, سولماز (1395) مقایسه تاثیر بریمونیدین و لاتاپروست در پیشگیری از افزایش فشار داخل چشمی بدنبال یاگ لیزر کپسولوتومی خلفی در مراجعین به درمانگاه چشم اردبیل. International Journal of Basic & Clinical Pharmacology ــ 6 (1). ص.ص.189-193. شاپا 2003-2319
متن کامل
|
متنی
431kB |
آدرس اینترنتی رسمی : http://www.ijbcp.com
عنوان انگليسی
Compare Brimonidine 0.2% versus Latanoprost 0.005% (Xalatan) in preventing intraocular pressure after YAG laser posterior capsulotomy in patients visiting ophthalmology clinic in Ardabil city
خلاصه انگلیسی
Background: The transient increase of intraocular pressure (IOP) following neodymium YAG laser capsulotomy can occur in a significant number of patients, which requires prophylactic treatment with IOP reducing drugs, and in some patients, postoperative IOP monitoring. This study was performed to compare the efficacy of brimonidine 0.2% versus latanoprost0.005% (Xalatan) in preventing the IOP elevation after YAG laser posterior capsulotomy in patients visiting ophthalmology clinic in Alavi Hospital. Methods: This study was a randomized, double-blind clinical trial that included 100 patients who had developed posterior capsule opacification (PCO) as a result of previous cataract surgery and were candidate for undergoing YAG laser posterior capsulotomy. The patients were randomly divided into two groups of 50 patients. One group received brimonidine 0.2% one hour before surgery, and the other group received Xalatan 0.005% in the night before laser surgery. In both groups the patients' IOP was measured in baseline, 1, 2, 3, 24 hours, 3 days and one week after surgery. The gathered data were analyzed using statistical methods in SPSS.16. Results: The mean IOP, 1, 2, 3, and 24 hours, 3 days, and one week after surgery didn't show any significant difference between two groups. IOP one hour before surgery changed significantly compared to one hour after surgery and a statistically significant relationship was found between the two groups, though at other times of measurement, the differences were not significant. Conclusions: Results showed that using Brimonidine 0.2% or Latanoprost 0.005% as prophylactic before YAG laser posterior capsulotomy could be effective in preventing IOP after treatment.
نوع سند : | مقاله |
---|---|
زبان سند : | انگلیسی |
نویسنده اول : | حبیب اوجاقی |
نویسنده مسئول : | رحیم معصومی |
ضریب تاثیر و نمایه مجلات: | Indexed in: Index Copernicus , DOAJ, Index Medicus for South-East Asia Region (WHO), CrossRef, EBSCO , Ulrichsweb, Google Scholar, |
کلیدواژه ها (انگلیسی): | Brimonidine, Latanoprost, Xalatan, YAG laser capsulotomy |
موضوعات : | QV فارماکولوژی |
بخش های دانشگاهی : | دانشكده پزشكي > گروه جراحی |
کد شناسایی : | 8270 |
ارائه شده توسط : | دکتر فیروز امانی |
ارائه شده در تاریخ : | 09 دی 1395 07:55 |
آخرین تغییر : | 09 دی 1395 07:55 |
فقط پرسنل کتابخانه صفحه کنترل اسناد